CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 126 enrolled
Drug / intervention
LD118033 contact lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01539694
NCT01539694N/ACompleted

A Study to Evaluate the Product Performance of a Low Add MultiFocal Soft Contact Lens

Bausch & Lomb Incorporated·interventional·Posted Feb 27, 2012·Updated Sep 30, 2020

In Brief

A clinical study evaluating LD118033 contact lens and PureVision multifocal contact lens for Presbyopia. Completed, enrolled 126 participants across 1 site.

Detailed Summary

The objective of this study is to evaluate the product performance of an investigational multifocal low add soft contact lens.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 27, 2012
Enrollment StartJan 1, 2012
Primary CompletionFeb 1, 2012
Study CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.3 years ago

Interventions

LD118033 contact lensdevice

Multifocal contact lens worn on a daily wear basis for 1 week

PureVision multifocal contact lensdevice

PureVision multifocal contact lens worn on a daily wear basis for 1 week.